[1] Rizzo A, Ricci AD, Frega G, et al. How tochoose between percutaneous transhepatic and endoscopic biliary drainage in malignant obstructive jaundice: an ipdated systematic review and meta-analysis. In Vivo, 2020, 34(4):1701-1714. [2] Xu X, Zhang X. Theapplication of intravoxel incoherent motion diffusion-weighted imaging in the diagnosis of hilar obstructive jaundice. J Comput Assist Tomogr, 2019, 43(2):228-234. [3] 周梦豪,邓毅磊,杨旭东,等.壶腹部周围癌和胰头癌导致的梗阻性黄疸行胆肠吻合术后发生上消化道梗阻的危险因素分析.中华普通外科杂志,2021,36(5):382-383. [4] Hiratani S, Mori R, Ota Y, et al. Asimple and easily reproducible model of reversible obstructive jaundice in rats. In Vivo, 2019, 33(3):699-706. [5] Soares PFDC, Gestic MA, Utrini MP, et al. Epidemiological profile, referral routes and diagnostic accuracy of cases of acute cholangitis among individuals with obstructive jaundice admitted to a tertiary-level university hospital: a cross-sectional study. Sao Paulo Med J, 2019, 137(6):491-497. [6] Kongkam P, Orprayoon T, Boonmee C, et al. ERCP plus endoscopic ultrasound-guided biliary drainage versus percutaneous transhepatic biliary drainage for malignant hilar biliary obstruction: a multicenter observational open-label study. Endoscopy, 2021, 53(1):55-62. [7] Riaz A, Pinkard JP, Salem R, et al. Percutaneous management of malignant biliary disease. J Surg Oncol, 2019, 120(1):45-56. [8] O'Brien S, Bhutiani N, Egger ME, et al. Comparing the efficacy of initial percutaneous transhepatic biliary drainage and endoscopic retrograde cholangiopancreatography with stenting for relief of biliary obstruction in unresectable cholangiocarcinoma. Surg Endosc, 2020, 34(3):1186-1190. [9] Bokemeyer A, Müller F, Niesert H, et al. Percutaneous-transhepatic-endoscopic rendezvous procedures are effective and safe in patients with refractory bile duct obstruction. United European Gastroenterol J, 2019, 7(3):397-404. [10] Zhao Z, Song J, Fan X, et al. Primaryclinical application of Y-shaped jogged stent implantation in patients with malignant hilar biliary obstruction. J Gastrointest Surg, 2019, 23(4):745-750. [11] 于皆平,沈志祥,罗和生.实用消化病学.北京:科学出版社,2007:566-568. [12] Anderloni A, Troncone E, Fugazza A, et al. Lumen-apposing metal stents for malignant biliary obstruction: Is this the ultimate horizon of our experience? World J Gastroenterol, 2019, 25(29):3857-3869. [13] Elkilany A, Alwarraky M, Geisel D, et al. Stent performance in palliative transhepatic treatment of malignant biliary obstruction: a randomized study comparing covered versus uncovered stents. Acta Radiol, 2020, 61(12):1591-1599. [14] 庄东海,张振,吴善彬.超声内镜引导下胆汁引流治疗ERCP治疗失败的恶性梗阻性黄疸患者疗效初步研究.实用肝脏病杂志,2020,23(5):735-738. [15] 中华医学会外科学分会胆道外科学组,白求恩公益基金会肝胆专业委员会,中华外科杂志编辑部.加速康复理念在梗阻性黄疸规范治疗中应用的专家共识.中华外科杂志,2021,59(4):241-248. [16] Chikamori F, Yukishige S, Ueta K, et al. Hemoperitoneum and sepsis from transhepatic gallbladder perforation of acute cholecystitis:a case report. Radiol Case Rep, 2020, 15(11):2241-2245. [17] Dilek FH, Karasu Ş, Dilek ON. Heterotopic chondroid tissue of the main bile duct mimickingklatskin tumor: case report and review of the literature. Clin J Gastroenterol, 2019, 12(3):205-208. [18] 马海婧,魏兰兰,张涛.Ⅱ、Ⅲ、Ⅳ型肝门部胆管癌患者术前减黄的引流相关性胆管炎发生率的队列研究.中华普外科手术学杂志(电子版),2020,14(2):182-185. [19] Sugawara S, Sone M, Morita S, et al. Radiologicassessment for endoscopic US-guided biliary drainage. Radiographics, 2020, 40(3):667-683. [20] Meena R, Aggarwal A, Bhattacharya A, et al. Non traumatic vertebral lesions: incremental utility of PET-CT over MRI and FNAC in a suggested diagnostic algorithm. Br J Neurosurg, 2019, 33(1):25-29. |